Literature DB >> 10727782

The role of 6R-tetrahydrobiopterin in the nervous system.

K Koshimura1, Y Murakami, J Tanaka, Y Kato.   

Abstract

In addition to its cofactor activities for aromatic L-amino acid hydroxylases and nitric oxide synthase (NOS), 6R-tetrahydrobiopterin (6R-BH(4)) shows diverse actions on neurons. Dopamine release from the rat striatum or PC12 cells was stimulated by 6R-BH(4). The action of 6R-BH(4) was independent of its cofactor activities and stereospecific. Ca(2+) channels in rat brain and PC12 cells were activated by 6R-BH(4) via cAMP-protein kinase A pathway. Membrane potential of PC12 cells was deplorized by 6R-BH(4). Thus, it is assumed that 6R-BH(4) acts on its specific action site (possibly outside of the cell membrane) to stimulate dopamine release by activating Ca(2+) channels. Apoptosis induced by depletion of serum and nerve growth factor in PC12 cells was prevented by 6R-BH(4). The cell surviving effect of 6R-BH(4) was also mediated by activation of Ca(2+) channels and cAMP-protein kinase A pathway. However, since 6R-BH(4) did not activate mitogen activated protein kinase, it did not support neuronal differentiation. Nitric oxide (NO)-induced cell death was prevented by 6R-BH(4) in PC12 cells. NOS activity was not changed by exogenous 6R-BH(4), but NO metabolites in culture medium were decreased by 6R-BH(4). When endogenous 6R-BH(4) was reduced by inhibition of biosynthesis, cell death was induced in PC12 cells. Superoxide is observed to be generated during autoxidation of 6R-BH(4). Superoxide producing system mimicked the cell protective action of 6R-BH(4) against NO toxicity. Thus, it is considered that 6R-BH(4) protects PC12 cells against NO toxicity by generating superoxide during its autoxidation. These results raised the possibility that 6R-BH(4) is a self-protective factor against NO toxicity in NO producing neurons. Our findings indicate that 6R-BH(4) regulates neuronal activities in the brain and that 6R-BH(4) can be a promising drug for neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727782     DOI: 10.1016/s0301-0082(99)00059-3

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  6 in total

1.  Simultaneous determination of all forms of biopterin and neopterin in cerebrospinal fluid.

Authors:  Pierre Guibal; Nathalie Lévêque; Diane Doummar; Nicolas Giraud; Emmanuel Roze; Diana Rodriguez; Rémy Couderc; Thierry Billette De Villemeur; Fathi Moussa
Journal:  ACS Chem Neurosci       Date:  2014-04-08       Impact factor: 4.418

Review 2.  Tetrahydrobiopterin and Its Multiple Roles in Neuropsychological Disorders.

Authors:  S Swathi Krishna; Samson K Wilson
Journal:  Neurochem Res       Date:  2022-02-10       Impact factor: 3.996

3.  Tetrahydrobiopterin Supplementation: Elevation of Tissue Biopterin Levels Accompanied by a Relative Increase in Dihydrobiopterin in the Blood and the Role of Probenecid-Sensitive Uptake in Scavenging Dihydrobiopterin in the Liver and Kidney of Rats.

Authors:  Akiko Ohashi; Yusuke Saeki; Tomonori Harada; Masako Naito; Tomihisa Takahashi; Shin Aizawa; Hiroyuki Hasegawa
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

4.  Single-Step Rapid Diagnosis of Dopamine and Serotonin Metabolism Disorders.

Authors:  Aurélien Lo; Pierre Guibal; Diane Doummar; Diana Rodriguez; Jean-Yves Hautem; Rémy Couderc; Thierry Billette De Villemeur; Emmanuel Roze; Pierre Chaminade; Fathi Moussa
Journal:  ACS Omega       Date:  2017-09-19

Review 5.  Pain-relief learning in flies, rats, and man: basic research and applied perspectives.

Authors:  Bertram Gerber; Ayse Yarali; Sören Diegelmann; Carsten T Wotjak; Paul Pauli; Markus Fendt
Journal:  Learn Mem       Date:  2014-03-18       Impact factor: 2.460

Review 6.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.

Authors:  Sylvie Vancassel; Lucile Capuron; Nathalie Castanon
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.